Dose Finding Study of [177Lu]Lu-NeoB in Combination With RT and TMZ in Newly Diagnosed GBM.

Condition:   Newly Diagnosed Glioblastoma Interventions:   Drug: [177Lu]Lu-NeoB;   Drug: [68Ga]Ga-NeoB;   Other: Temozolomide Sponsor:   Novartis Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - February 22, 2023 Category: Research Source Type: clinical trials